Edaravone-Dexborneol slows down pathological progression and cognitive decline via inhibiting S100A9 in APPswe/PS1dE9 mice.

Alzheimers Res Ther · 2025 · PMC12181868 · PMID 40544243

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Consistent with a previous study on EDA [ 14 ], the expression of the β-secretase BACE1 decreased significantly, whereas the expression of the α-secretase ADAM10 showed an increasing trend in the APP + EDB group.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.